These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 4413891

  • 1. Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.
    Lippmann W.
    Prostaglandins; 1974 Aug 10; 7(3):231-46. PubMed ID: 4413891
    [No Abstract] [Full Text] [Related]

  • 2. Oral gastric acid secretion-inhibitory activity and anti-ulcer activity of synthetic prostaglandin analogues: C-15 epimers of 15-hydroxy-15-methyl-9-oxoprostanoic acid (AY-22,469).
    Lippmann W.
    Prostaglandins; 1974 Aug 10; 7(3):223-9. PubMed ID: 4414938
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of gastric acid secretion in the rat by synthetic prostaglandin analogues.
    Lippmann W.
    Ann N Y Acad Sci; 1971 Apr 30; 180():332-5. PubMed ID: 5286101
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of gastric acid secretion in the rat by orally-administered synthetic prostaglandin analogues: enantiomorphs of 15-hydroxy-15-methyl-9-oxoprostanoic acid.
    Lippmann W.
    J Pharm Pharmacol; 1974 Oct 30; 26(10):831-3. PubMed ID: 4156547
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
    Robert A, Schultz JR, Nezamis JE, Lancaster C.
    Gastroenterology; 1976 Mar 30; 70(3):359-70. PubMed ID: 174967
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sympathomimetic amines and gastric secretion in rats.
    Fjalland B.
    Acta Pharmacol Toxicol (Copenh); 1974 Oct 30; 35(4):293-9. PubMed ID: 4479360
    [No Abstract] [Full Text] [Related]

  • 11. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat.
    Robert A, Nezamis JE, Phillips JP.
    Gastroenterology; 1968 Oct 30; 55(4):481-7. PubMed ID: 5698627
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of indomethacin-induced gastric ulceration in the rat by perorally-administered synthetic and natural prostaglandin analogues.
    Lippmann W.
    Prostaglandins; 1974 Jul 10; 7(1):1-10. PubMed ID: 4852476
    [No Abstract] [Full Text] [Related]

  • 13. Effects of prostaglandins on the stomach and the intestine.
    Robert A.
    Prostaglandins; 1974 Jun 25; 6(6):523-32. PubMed ID: 4366018
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro.
    Whittle BJ, Boughton-Smith NK, Moncada S, Vane JR.
    Prostaglandins; 1978 Jun 25; 15(6):955-67. PubMed ID: 358297
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat.
    Main IH, Whittle BJ.
    Br J Pharmacol; 1973 Nov 25; 49(3):428-36. PubMed ID: 4149696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.